rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5-6
|
pubmed:dateCreated |
1995-12-28
|
pubmed:abstractText |
The effect of Salbutamol (Polfa) inhalation on small airway function was studied in 20 patients with stage II sarcoidosis and 8 healthy volunteers. MEFV values and dynamic compliance were assessed. A significant statistical increase of FEV1, MEF50, Cdyn20 and Cdyn60 were seen only in healthy volunteers. In patients with sarcoidosis the assessed parameters were not effected by the Salbutamol inhalation.
|
pubmed:language |
pol
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0867-7077
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
63
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
264-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7581055-Administration, Inhalation,
pubmed-meshheading:7581055-Adult,
pubmed-meshheading:7581055-Albuterol,
pubmed-meshheading:7581055-Bronchodilator Agents,
pubmed-meshheading:7581055-Female,
pubmed-meshheading:7581055-Forced Expiratory Volume,
pubmed-meshheading:7581055-Humans,
pubmed-meshheading:7581055-Lung Diseases,
pubmed-meshheading:7581055-Male,
pubmed-meshheading:7581055-Maximal Expiratory Flow-Volume Curves,
pubmed-meshheading:7581055-Sarcoidosis
|
pubmed:year |
1995
|
pubmed:articleTitle |
[Effect of salbutamol inhalation on small airways function in patients with sarcoidosis].
|
pubmed:affiliation |
Kliniki Ftizjopneumonologii Sl. AM.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
English Abstract,
Controlled Clinical Trial
|